COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative.
Charles D VarnellLyndsay A HarshmanChunyan LiuLaurie SmithSamhar Al-AkashGina-Marie BarlettaPaul BrakemanAbanti ChaudhuriPaul FadakarLauren GaleaRouba GarroCaroline GluckDavid B KershawDebora MatossianHiren P PatelCaitlin PetersonCozumel PruetteSaritha RanabothuNancy RodigPamela SingerJudith Sebestyen VanSicklePatricia L WengLara Danziger-IsakovMichael E SeifertDavid K HooperPublished in: Pediatric nephrology (Berlin, Germany) (2022)
Despite the increase in testing and positive tests over this study period, the incidence of allograft loss or death related to COVID-19 remained extremely low, with allograft loss or death each occurring in < 1% of COVID-19-positive patients and in less than < 0.1% of all transplant patients within the IROC cohort. A higher resolution version of the Graphical abstract is available as Supplementary information.